SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-002637
Filing Date
2020-05-14
Accepted
2020-05-14 09:01:51
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 1036619
2 CERTIFICATION ipix_ex311.htm EX-31.1 9019
3 CERTIFICATION ipix_ex321.htm EX-32.1 3056
  Complete submission text file 0001477932-20-002637.txt   5845305

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ipix-20200331.xml EX-101.INS 957839
5 XBRL TAXONOMY EXTENSION SCHEMA ipix-20200331.xsd EX-101.SCH 105244
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20200331_lab.xml EX-101.LAB 480580
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20200331_cal.xml EX-101.CAL 26042
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20200331_pre.xml EX-101.PRE 441384
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20200331_def.xml EX-101.DEF 321067
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 20875500
SIC: 2834 Pharmaceutical Preparations